BERTONI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 1.423
NA - Nord America 1.366
AS - Asia 338
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.131
Nazione #
US - Stati Uniti d'America 1.340
IE - Irlanda 425
SE - Svezia 284
DE - Germania 220
IT - Italia 175
UA - Ucraina 160
FI - Finlandia 104
CN - Cina 84
IN - India 83
HK - Hong Kong 64
SG - Singapore 41
VN - Vietnam 35
CA - Canada 25
FR - Francia 20
TR - Turchia 18
GB - Regno Unito 16
BE - Belgio 14
IR - Iran 11
EU - Europa 3
CZ - Repubblica Ceca 2
KR - Corea 2
NL - Olanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
HN - Honduras 1
RU - Federazione Russa 1
Totale 3.131
Città #
Dublin 425
Jacksonville 308
Dearborn 158
Chandler 133
Wilmington 91
Ann Arbor 78
Piemonte 69
Hong Kong 64
Lawrence 54
Princeton 54
San Mateo 49
Andover 45
Beijing 38
Dong Ket 35
Ashburn 26
Bremen 26
Singapore 22
Toronto 20
Boardman 18
Monmouth Junction 15
Brussels 14
Kocaeli 12
Fairfield 10
Grafing 10
Helsinki 10
Houston 10
Woodbridge 10
Philadelphia 9
Augusta 8
Seattle 8
Norwalk 7
Savignano Sul Panaro 7
Ankara 6
Ardabil 6
Milan 6
Bologna 5
Hefei 5
Moncalieri 5
Nanjing 5
Novara 5
Zanjan 5
Hangzhou 4
Kunming 4
Sacramento 4
San Giuliano Milanese 4
Udine 4
Arona 3
Dallas 3
Leawood 3
Sommacampagna 3
Vercelli 3
Winnipeg 3
Wuhan 3
Xian 3
Brno 2
Fuzhou 2
Guangzhou 2
Jinan 2
Legnano 2
Nijmegen 2
Quzhou 2
Sesto Fiorentino 2
Turin 2
Vigevano 2
Alagna Valsesia 1
Baotou 1
Bari 1
Bellinzago Novarese 1
Cardano 1
Castelnuovo Bormida 1
Cesano Maderno 1
Chengdu 1
Cologne 1
Düsseldorf 1
Fucecchio 1
Karlsruhe 1
Ladispoli 1
Minneapolis 1
Montréal 1
Mumbai 1
Munich 1
Mülheim 1
Nanchang 1
Nantong 1
Ottawa 1
Quattordio 1
Riva 1
Rivoli 1
Saint Paul 1
San Diego 1
Santa Clara 1
Shanghai 1
Shenyang 1
Tappahannock 1
Taramani 1
Tegucigalpa 1
Tianjin 1
Torino 1
Trieste 1
Wenzhou 1
Totale 1.991
Nome #
Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors 140
Identification of a novel DGKa inhibitor for XLP-1 therapy by virtual screening 119
A luminal EF-hand mutation in STIM1 in mice causes the clinical hallmarks of tubular aggregate myopathy. 96
Factor V marks platelet-primed megakaryocytes 86
8-prenylnaringenin, a novel inhibitor of platelet aggregation 84
Integrins in T Cell Physiology 78
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 74
Preliminary analysis of the role of diacylglycerol kinase alpha in megakaryopoiesis and platelet function 73
The small proteoglycan decorin supports adhesion and activation of human platelets 72
Lysophosphatidic acid induces protein tyrosine phosphorilation in the absence of phospholipase C activation in human platelets 71
The endocannabinoid 2-arachidonoylglycerol regulates platelet function 71
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 69
Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling 68
Clustering of integrin alphaIIb-beta3 differently regulates tyrosine phosphorylation of pp72syk, PLCgamma2 and pp125FAK in concanavalin A-stimulated platelets 67
Interaction of CD38 with the platelet cytoskeleton induced by thrombin and modulation of the ADP-ribosyl cyclase activity 66
The diacylglycerol kinase α/atypical PKC/β1 integrin pathway in SDF-1α mammary carcinoma invasiveness. 66
Concanavalin A-induced tyrosine phosphorylation of Syk, PLCgamma2 and FAK in platelets: role of glycoprotein IIb-IIIa 65
On the mechanism of rap proteins interaction with platelet cytoskeleton. (PD 1094) 64
Expression of CD38 and synthesis of cyclic ADP-ribose by human platelets" 63
Regulation of rap proteins translocation to the cytoskeleton by tyrosine kinases and FcgammaII receptor in von Willebrand factor-stimulated platelets (#1395) 61
Inhibition of collagen-dependent platelet aggregation by 8-prenylnaringenin 61
A diet supplemented with ALA-rich flaxseed prevents cardiomyocyte apoptosis by regulating caveolin-3 expression. 61
Effect of dehydroepiandrosterone and dehydroepiandrosterone-sulfate on platelet function 60
The FcgammaII receptor plays an essential role in platelet activation by von Willebrand factor 59
Dehydroepiandrosterone-sulfate inhibits thrombin-induced platelet aggregation 56
Rap1B and Rap2B translocation to the cytoskeleton by von Willebrand factor involves FcgammaII receptor-mediated protein tyrosine phosphorylation 55
A role for the fcgammaRIIa receptor in platelet activation by von Willebrand factor. (P1163) 53
Human platelet express authentic CB(1) and CB(2) receptors 53
Clustering of integrin aIIb-b3 differently regulates tyrosine pohsphorylation of pp72syk, PLCg2 and p125FAK in Concanavalin A-stimulated platelets 51
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 51
17beta-estradiol potentiates thrombin-dependent alfaIIbbeta3 activation and platelet aggregation 50
The phytoestrogen 8-prenylnaringenin inhibits agonist-dependent activation of human platelets. 50
Hydrolysis of NADP+ by platelet CD38 in the absence of synthesis and degradation of cyclic ADP-ribose 2'-phosphate 49
Activation of human platelets by lysophosphatidic acid 48
Agonist-induced actin polymerization is required for the irreversibility of platelet aggregation 48
Regulation of CD38-mediated production of cADPR by platelet stimulation and cytoskeleton reorganization (PD633) 47
Cytoskeleton-dependent inhibition of the ADP-ribosyl cyclase activity of CD38 in thrombin-stimulated platelets 47
The small GTPase Rap1b is a modulator of agonist-induced activation of platelet integrin alphaIIbbeta3 (#752) 46
The oestrogen receptor GPER is expressed in human haematopoietic stem cells but not in mature megakaryocytes 44
The platelet cytoskeleton regulates the aggregation-dependent synthesis of phosphatidyl inositol 3,4 bisphosphate induced by thrombin 44
Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process 44
Platelet activation by von Willebrand factor requires coordinated signaling through thromboxane A2 and Fc gamma IIA receptor 43
Thrombin induces the association of cyclic ADP-ribose-synthesizing CD38 with the platelet cytoskeleton 42
Nongenomic effects of 17beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor beta and Src kinase 42
Mechanisms for thrombopoietin-induced potentiation of platelet aggregation. 41
The oestrogen receptor GPER is expressed in human haematopoietic stem cells but not in mature megakaryocytes. 41
Membrane lipid rafts coordinate estrogen-dependent signaling in human platelets 40
Relationships between Rap1b, affinity modulation of integrin alphaIIbbeta3, and the actin cytoskeleton 39
Megakaryocytes derived from embryonic stem cells implicate exchange factor CalDAG-GEFI in integrin signaling (#511) 39
Study of the role of membrane lipid rafts in estrogen signaling in human platelets (P1493) 38
Interaction of the low-molecular-weight GTP-binding protein rap2 with the platelet cytoskeleton is mediated by direct binding to the actin filaments 38
Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin alpha(IIb)beta(3) activation and platelet aggregation 35
Platelet interaction with CNBr peptides from type II collagen via integrin alpha2beta1 34
The endocannabinoid 2-arachidonoylglycerol activates human platelets through non-CB(1)/CB(2) receptors 30
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathy 25
Totale 3.157
Categoria #
all - tutte 14.120
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020660 6 1 53 3 106 102 126 18 62 116 57 10
2020/2021473 55 1 60 1 52 17 64 14 65 24 71 49
2021/2022521 13 55 89 79 26 8 57 9 29 8 67 81
2022/2023948 58 42 43 35 77 102 14 55 476 9 23 14
2023/2024249 30 9 27 6 46 6 60 12 1 1 10 41
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 3.157